Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-(2-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | - |
Homo sapiens | |
2-(3-bromophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | - |
Homo sapiens | |
2-(3-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | - |
Homo sapiens | |
2-(4-aminophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | - |
Homo sapiens | |
2-(4-bromophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | - |
Homo sapiens | |
2-(4-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | - |
Homo sapiens | |
2-biphenyl-4-yl-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | - |
Homo sapiens | |
2-[4-(diethylamino)phenyl]-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | - |
Homo sapiens | |
2-[4-(dimethylamino)phenyl]-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | - |
Homo sapiens | |
N-(5-nitro-1H-indazol-3-yl)-2-phenylacetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(3-fluorophenyl)acetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(3-methylphenyl)acetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-fluorophenyl)acetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-hydroxyphenyl)acetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-methylphenyl)acetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-piperidin-1-ylphenyl)acetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-pyridin-4-ylphenyl)acetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-naphthalen-1-ylacetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-naphthalen-2-ylacetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-phenylacetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-[4-(methylsulfanyl)phenyl]acetamide | - |
Homo sapiens | |
N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-[4-(methylsulfonyl)phenyl]acetamide | - |
Homo sapiens | |
N-[5-(2,5-dioxoimidazolidin-1-yl)-1H-indazol-3-yl]-2-phenylacetamide | - |
Homo sapiens | |
N-[5-(2-oxopiperidin-1-yl)-1H-indazol-3-yl]-2-phenylacetamide | - |
Homo sapiens | |
N-[5-(2-oxopyrrolidin-1-yl)-1H-indazol-3-yl]-2-phenylacetamide | - |
Homo sapiens | |
N-[5-(dibutylamino)-1H-indazol-3-yl]-2-phenylacetamide | - |
Homo sapiens | |
N-[5-(diethylamino)-1H-indazol-3-yl]-2-phenylacetamide | - |
Homo sapiens | |
N-[5-(dipropylamino)-1H-indazol-3-yl]-2-phenylacetamide | - |
Homo sapiens | |
N-[5-(ethylamino)-1H-indazol-3-yl]-2-phenylacetamide | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Homo sapiens | P06493 | - |
- |
Homo sapiens | P24941 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
A-549 cell | - |
Homo sapiens | - |
EJ cell | - |
Homo sapiens | - |
HCT-116 cell | - |
Homo sapiens | - |
SW-620 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + histone H1 | - |
Homo sapiens | ADP + phosphorylated histone H1 | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Cdk1 | - |
Homo sapiens |
CDK2 | - |
Homo sapiens |
CDK4 | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
cyclin | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000007 | - |
with isozyme CDK2 | Homo sapiens | 2-(3-bromophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000007 | - |
with isozyme CDK2 | Homo sapiens | 2-(4-bromophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000007 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-methylphenyl)acetamide | |
0.000009 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-hydroxyphenyl)acetamide | |
0.000009 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-naphthalen-2-ylacetamide | |
0.00001 | - |
with isozyme CDK2 | Homo sapiens | 2-[4-(dimethylamino)phenyl]-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.00001 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(3-methylphenyl)acetamide | |
0.00001 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-[4-(methylsulfanyl)phenyl]acetamide | |
0.000012 | - |
with isozyme CDK1 | Homo sapiens | 2-(4-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000012 | - |
with isozyme CDK2 | Homo sapiens | 2-(4-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000014 | - |
with isozyme CDK2 | Homo sapiens | 2-biphenyl-4-yl-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000016 | - |
with isozyme CDK2 | Homo sapiens | 2-(4-aminophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.00002 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-naphthalen-1-ylacetamide | |
0.000022 | - |
with isozyme CDK1 | Homo sapiens | 2-(4-bromophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000022 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-[4-(methylsulfonyl)phenyl]acetamide | |
0.000028 | - |
with isozyme CDK1 | Homo sapiens | 2-[4-(dimethylamino)phenyl]-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000028 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-hydroxyphenyl)acetamide | |
0.00003 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(3-fluorophenyl)acetamide | |
0.00003 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(3-fluorophenyl)acetamide | |
0.00003 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-piperidin-1-ylphenyl)acetamide | |
0.00003 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-pyridin-4-ylphenyl)acetamide | |
0.000034 | - |
with isozyme CDK1 | Homo sapiens | 2-(3-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000034 | - |
with isozyme CDK2 | Homo sapiens | 2-(3-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000036 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-phenylacetamide | |
0.00004 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-methylphenyl)acetamide | |
0.00004 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-[4-(methylsulfanyl)phenyl]acetamide | |
0.00004 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-naphthalen-2-ylacetamide | |
0.00004 | - |
with isozyme CDK2 | Homo sapiens | 2-[4-(diethylamino)phenyl]-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000042 | - |
with isozyme CDK1 | Homo sapiens | 2-biphenyl-4-yl-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.000047 | - |
with isozyme CDK1 | Homo sapiens | 2-(3-bromophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.00005 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(3-methylphenyl)acetamide | |
0.00005 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-fluorophenyl)acetamide | |
0.00005 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-fluorophenyl)acetamide | |
0.00006 | - |
with isozyme CDK1 | Homo sapiens | 2-[4-(diethylamino)phenyl]-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.00006 | - |
with isozyme CDK1 | Homo sapiens | 2-(4-aminophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.00006 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-pyridin-4-ylphenyl)acetamide | |
0.000067 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-naphthalen-1-ylacetamide | |
0.00008 | - |
with isozyme CDK1 | Homo sapiens | 2-(2-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.00008 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-phenylacetamide | |
0.00008 | - |
with isozyme CDK2 | Homo sapiens | 2-(2-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.00015 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-piperidin-1-ylphenyl)acetamide | |
0.00017 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(2-oxopyrrolidin-1-yl)-1H-indazol-3-yl]-2-phenylacetamide | |
0.0002 | - |
with isozyme CDK1 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-[4-(methylsulfonyl)phenyl]acetamide | |
0.0002 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(diethylamino)-1H-indazol-3-yl]-2-phenylacetamide | |
0.00021 | - |
with isozyme CDK4 | Homo sapiens | 2-[4-(dimethylamino)phenyl]-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.0005 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(ethylamino)-1H-indazol-3-yl]-2-phenylacetamide | |
0.00071 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(3-fluorophenyl)acetamide | |
0.00075 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-piperidin-1-ylphenyl)acetamide | |
0.00089 | - |
with isozyme CDK4 | Homo sapiens | 2-(2-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.001 | - |
with isozyme CDK4, IC50 above 0.001 mM | Homo sapiens | 2-[4-(diethylamino)phenyl]-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.00105 | - |
with isozyme CDK4 | Homo sapiens | 2-(3-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.0013 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-[4-(methylsulfanyl)phenyl]acetamide | |
0.00133 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-pyridin-4-ylphenyl)acetamide | |
0.0014 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-[4-(methylsulfonyl)phenyl]acetamide | |
0.0016 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-naphthalen-2-ylacetamide | |
0.00175 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-hydroxyphenyl)acetamide | |
0.0018 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(dipropylamino)-1H-indazol-3-yl]-2-phenylacetamide | |
0.0018 | - |
with isozyme CDK4 | Homo sapiens | 2-(3-bromophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.0018 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-methylphenyl)acetamide | |
0.002 | - |
with isozyme CDK2 | Homo sapiens | N-(5-nitro-1H-indazol-3-yl)-2-phenylacetamide | |
0.002 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(2,5-dioxoimidazolidin-1-yl)-1H-indazol-3-yl]-2-phenylacetamide | |
0.002 | - |
with isozyme CDK4 | Homo sapiens | 2-(4-bromophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.002 | - |
with isozyme CDK4 | Homo sapiens | 2-(4-chlorophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.0022 | - |
with isozyme CDK4 | Homo sapiens | 2-biphenyl-4-yl-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.0022 | - |
with isozyme CDK4 | Homo sapiens | 2-(4-aminophenyl)-N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]acetamide | |
0.003 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-naphthalen-1-ylacetamide | |
0.003 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-fluorophenyl)acetamide | |
0.0037 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-phenylacetamide | |
0.004 | - |
with isozyme CDK4 | Homo sapiens | N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(3-methylphenyl)acetamide | |
0.0071 | - |
with isozyme CDK2 | Homo sapiens | N-[5-(2-oxopiperidin-1-yl)-1H-indazol-3-yl]-2-phenylacetamide | |
0.1 | - |
with isozyme CDK2, IC50 above 0.1 mM | Homo sapiens | N-[5-(dibutylamino)-1H-indazol-3-yl]-2-phenylacetamide |